INTRODUCTION: The aim of the international Reduction of Atherothrombosis for Continued Health (REACH) registry was to identify prospectively characteristics, risk factors, treatments, and cardiovascular event rates in stable outpatients with atherothrombotic disease, as well as in asymptomatic patients with risk factors for atherothrombotic disease. METHODS: A total of 512 physicians in Germany enrolled 4986 outpatients with documented atherothrombotic disease, as well as 608 asymptomatic patients with at least three risk factors for atherothrombotic disease, in the REACH registry. Patients will be followed for up to four years, with assessments being performed at regular intervals; the results of the one-year follow-up are presented here. RESULTS: The documented risk factors were hypertension (58.2%), hypercholesterolemia (74.6%), diabetes (37.6%), and obesity (28.1%). A large percentage of patients did not reach the therapeutic target values specified in current German and European S1 guidelines. After 1 year, 2.1% of the patients with symptomatic atherothrombotic disease and 1.5% of the patients with at least three cardiovascular risk factors had died of a cardiovascular event, whereas 5.8% of the former and 2.5% of the latter patient group had reached a combined endpoint consisting of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke. CONCLUSION: The traditional risk factors are common in patients with coronary heart disease, cerebrovascular disease (stroke and/or transient ischemic attack), or peripheral arterial occlusive disease. Many patients with these conditions or associated risk factors are not treated according to current guidelines. This may explain, at least in part, the high rates of cardiovascular events observed after one year.
INTRODUCTION: The aim of the international Reduction of Atherothrombosis for Continued Health (REACH) registry was to identify prospectively characteristics, risk factors, treatments, and cardiovascular event rates in stable outpatients with atherothrombotic disease, as well as in asymptomatic patients with risk factors for atherothrombotic disease. METHODS: A total of 512 physicians in Germany enrolled 4986 outpatients with documented atherothrombotic disease, as well as 608 asymptomatic patients with at least three risk factors for atherothrombotic disease, in the REACH registry. Patients will be followed for up to four years, with assessments being performed at regular intervals; the results of the one-year follow-up are presented here. RESULTS: The documented risk factors were hypertension (58.2%), hypercholesterolemia (74.6%), diabetes (37.6%), and obesity (28.1%). A large percentage of patients did not reach the therapeutic target values specified in current German and European S1 guidelines. After 1 year, 2.1% of the patients with symptomatic atherothrombotic disease and 1.5% of the patients with at least three cardiovascular risk factors had died of a cardiovascular event, whereas 5.8% of the former and 2.5% of the latter patient group had reached a combined endpoint consisting of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke. CONCLUSION: The traditional risk factors are common in patients with coronary heart disease, cerebrovascular disease (stroke and/or transient ischemic attack), or peripheral arterial occlusive disease. Many patients with these conditions or associated risk factors are not treated according to current guidelines. This may explain, at least in part, the high rates of cardiovascular events observed after one year.
Authors: L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes; Kevin Bell; Joseph Caporusso; Isabelle Durand-Zaleski; Kimihiro Komori; Johannes Lammer; Christos Liapis; Salvatore Novo; Mahmood Razavi; Johns Robbs; Nicholaas Schaper; Hiroshi Shigematsu; Marc Sapoval; Christopher White; John White; Denis Clement; Mark Creager; Michael Jaff; Emile Mohler; Robert B Rutherford; Peter Sheehan; Henrik Sillesen; Kenneth Rosenfield Journal: Eur J Vasc Endovasc Surg Date: 2006-11-29 Impact factor: 7.069
Authors: S Böhler; H Scharnagl; F Freisinger; T Stojakovic; H Glaesmer; J Klotsche; L Pieper; D Pittrow; W Kirch; H Schneider; G K Stalla; H Lehnert; A M Zeiher; S Silber; U Koch; G Ruf; W März; H-U Wittchen Journal: Atherosclerosis Date: 2006-03-20 Impact factor: 5.162
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand Journal: Lancet Date: 2005-11-05 Impact factor: 79.321
Authors: Deepak L Bhatt; Matthew T Roe; Eric D Peterson; Yun Li; Anita Y Chen; Robert A Harrington; Adam B Greenbaum; Peter B Berger; Christopher P Cannon; David J Cohen; C Michael Gibson; Jorge F Saucedo; Neal S Kleiman; Judith S Hochman; William E Boden; Ralph G Brindis; W Frank Peacock; Sidney C Smith; Charles V Pollack; W Brian Gibler; E Magnus Ohman Journal: JAMA Date: 2004-11-03 Impact factor: 56.272
Authors: R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham Journal: Eur Heart J Date: 2003-06 Impact factor: 29.983
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng Journal: Lancet Date: 2004 Sep 11-17 Impact factor: 79.321
Authors: Uwe Zeymer; Klaus G Parhofer; David Pittrow; Christiane Binz; Markus Schwertfeger; Tobias Limbourg; Joachim Röther Journal: Clin Res Cardiol Date: 2009-02-16 Impact factor: 5.460
Authors: Saskia H Meves; Thomas Hummel; Heinz G Endres; Nora Mayböck; Andreas F C Kaiser; Kay D Schröder; Katja Rüdiger; Ursula Overbeck; Achim Mumme; Andreas Mügge; Horst Neubauer Journal: J Thromb Thrombolysis Date: 2014 Impact factor: 2.300
Authors: Juergen R Schaefer; Anselm K Gitt; Frank Sonntag; Achim Weizel; Christina Jannowitz; Barbara Karmann; David Pittrow; Kurt Bestehorn Journal: Vasc Health Risk Manag Date: 2013-02-21
Authors: Stefanie Leistner; Steffen Benik; Inga Laumeier; Annerose Ziegler; Gabriele Nieweler; Christian H Nolte; Peter U Heuschmann; Heinrich J Audebert Journal: PLoS One Date: 2012-12-17 Impact factor: 3.240